Biomatériaux et Bioingénierie pour l'Innovation en Chirurgie/Biomaterials and Bioengineering for the Innovation in Surgery

Biomatériaux et Bioingénierie pour lInnovation en Chirurgie/生物材料和生物工程促进外科创新

• 批准号: CRC-2018-00091
• 负责人: Mantovani, Diego
• 金额: $ 14.57万
• 依托单位: Université Laval
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=695302
• 关键词: Biomat; riaux; et; Bioing; nierie

In the last decades, biomaterials, artificial organs and medical implants have been successful to improve quality of the life for millions. However, very rare are the applications for which biomaterials and medical devices are completely successful. Failures or clinical complications are often observed, with different incidences related to the applications. The CRC in Biomaterials and Bioengineering for Surgery short and medium term aim is to improve the clinical performances of medical devices that today are commercially available and implanted daily by clinicians. The overall long-term aim is to investigate specific methodologies for developing physiologically relevant models for assessing and predicting the clinical success of medical devices and drugs, as well as advancing regenerative medicine.

在过去的几十年里，生物材料、人造器官和医疗植入物已经成功地改善了数百万人的生活质量。然而，生物材料和医疗器械的应用非常罕见。经常观察到失效或临床并发症，其发生率与应用相关。CRC在生物材料和生物工程外科短期和中期的目标是提高医疗器械的临床性能，今天是市售和植入的临床医生每天。总体长期目标是研究开发生理相关模型的具体方法，以评估和预测医疗器械和药物的临床成功，以及推进再生医学。